Ibogaine Research: Why Progress Is Slow
Ibogaine research moves slowly for structural reasons: drug scheduling, patents, cardiac risk, supply, and blinding, and some of those are changing.
Read the article →Expert-reviewed resources to help you make informed decisions about ibogaine therapy
Detailed information on medical screening, dosing protocols, and clinical procedures used in professional treatment centers.
Learn MoreComprehensive safety protocols, contraindications, and medical screening requirements to ensure patient safety.
Read GuidelinesAccess to peer-reviewed studies, clinical trial data, and research on efficacy for various conditions.
View ResearchResources for patients and families, including preparation guides, aftercare information, and support networks.
Get SupportObjective criteria for evaluating treatment centers, including safety protocols, medical staff, and facility standards.
Compare ClinicsAnswers to common questions about ibogaine treatment, costs, preparation, and what to expect during therapy.
Browse FAQsOur comprehensive resource is referenced by medical professionals, treatment centers, and patients seeking evidence-based information about ibogaine therapy.
Ibogaine represents one of the most promising developments in addiction medicine. The clinical evidence for its efficacy in interrupting opioid dependence continues to grow, supported by both preclinical research and observational studies.
Published Clinical Research, 2024–2026Ibogaine research moves slowly for structural reasons: drug scheduling, patents, cardiac risk, supply, and blinding, and some of those are changing.
Read the article →Ibogaine for Fentanyl Addiction: Clinical Protocol, Safety Considerations & Real Outcomes Author: Dr. JJ Arellano, MD | Published: October 15, 2026 | Read Time: 22 minutes --- The Crisis That Traditional Treatment Can't Solve Alone Jennifer had a legitimate pain prescription aft
Read the article →How ibogaine therapy differs from MDMA, psilocybin, ketamine and ayahuasca in duration, mechanism, risk profile and what each is actually used for.
Read the article →PTSD Psychedelic Breakthrough 2026: FDA Momentum + Treatment Results From the Front Lines Author: Dr. JJ Arellano, MD | Published: October 15, 2026 | Read Time: 18 minutes --- The Crisis That Changed Everything Marcus was an IED detection specialist in Kandahar. Twelve years lat
Read the article →Fentanyl Addiction Treatment: Ibogaine vs. Methadone vs. Buprenorphine in 2026 Jennifer stared at the fentanyl patch on her arm. What started as legitimate pain management after a car accident eighteen months ago had spiraled into dependence. Her doctor had tapered her dose twice, but within day
Read the article →Ibogaine for fentanyl addiction follows different rules than heroin, from longer stabilization to stricter cardiac screening and more cautious dosing.
Read the article →